Outlook Therapeutics, Inc. 8-K

What Happened
Outlook Therapeutics, Inc. (OTLK) filed a Form 8‑K on December 19, 2025 (Item 2.02) announcing its financial results for the fourth fiscal quarter and full fiscal year ended September 30, 2025. The company furnished a press release with those results as Exhibit 99.1 to the Form 8‑K.

Key Details

• Filing date: December 19, 2025 (Form 8‑K, Item 2.02).
• Reporting period: Fourth fiscal quarter and fiscal year ended September 30, 2025.
• Exhibit: Press release reporting results is furnished as Exhibit 99.1 to the filing.
• Interactive data: Cover Page Interactive Data File included (Inline XBRL).

Why It Matters
The press release provides the company’s latest earnings and financial condition information (quarterly results, revenue and other performance metrics) for Q4 and FY2025, which investors use to assess Outlook Therapeutics’ recent performance and update valuations or models. Because the Form 8‑K simply furnishes the press release, investors should review Exhibit 99.1 for the specific figures (revenue, net income/loss, cash position, and any guidance) that could influence the stock price or investment decisions.